DMW - Deutsche Medizinische Wochenschrift, Table of Contents Dtsch Med Wochenschr 2007; 132(9): 437-441DOI: 10.1055/s-2007-970354 Übersicht | Review articleTelemedizin, Gynäkologie© Georg Thieme Verlag KG Stuttgart · New YorkTelemetrische Blutdruck- und Gewichtskontrolle in der SchwangerschaftTelemetric monitoring of blood pressure and body weight during pregnancyM. Middeke1 , F. Köhler2 , T. Schweizer3 , J. W. Dudenhausen4 1Blutdruckinstitut München 2Charité - Universitätsmedizin Berlin, Medizinische Klinik, Schwerpunkt Kardiologie, Angiologie 3Actimon GmbH, München 4Klinik für Geburtsmedizin, Charité, Universitätsmedizin Berlin Recommend Article Abstract Buy Article(opens in new window) Schlüsselwörter Telemedizin - Blutdruckmessung - Schwangerschaft - Präeklampsie - Eklampsie Key words telemedicine - blood pressure monitoring - pregnancy - preclampsia - eclampsia Full Text References Literatur 1 American College of Obstetricians and Gynecologists .Hypertension in pregnancy. ACOG 1996 2 Anon. Report on confidential enquiries into maternal deaths in the United Kingdom 1994 - 1996. London: Stationery Office 1998 3 Baeten J M, Bukusi E A, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health. 2001; 91 436-440 4 Barton J R, Istwan N B, Rhea D. et al . Cost-savings analysis of an outpatient management program for women with pregnanacy-related hypertensive conditions. Disease Management. 2006; 9 236-241 5 Biswas A, Choolani M A, Anandakumar C, Arulkumaran S. Ambulatory blood pressure monitoring in pregnancy induced hypertension. Acta Obstet Gynecol Scand. 1997; 76 829-833 6 Brown M A, Robinson A, Bowyer L, Buddle M L, Martin A, Hargood J L. et al . Ambulatory blood pressure monitoring in pregnancy: what is normal?. Am J Obstet Gynecol. 1998; 178 836-842 7 Butters L, Kennedy S, Rubin P C. Atenolol in essential hypertension during pregnancy. BMJ. 1990; 301 587-589 8 Cedergren M I. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004; 103 219-224 9 Chappell L C, Seed P T, Briley A L. et al . Effects of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomizied trial. Lancet. 1999; 354 810-816 10 Clapp J F, Seaward B L, Sleamaker R H, Hiser J. Maternal physiologic adaptations to early human pregnancy. Am J Obstet Gynecol. 1988; 159 1456-1460 11 Cnattingius S, Bergstrom R, Lipworth L, Kramer M S. Pregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med. 1998; 338 147-152 12 Cogswell M E, Yip R. The influence of fetal and maternal factors on the distribution of birthweight. Sem Perinatol. 1995; 19 222-240 13 Cooper W O, Hernandez-Diaz S, Arbogast P. et al . Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006; 354 2443-2451 14 von Dadelszen P, Ornstein M P, Bull S P. et al . Fall in mean arterial pressure and fetal growth restriction in pregnanacy hypertension: a meta-analysis. Lancet. 2000; 355 87-92 15 Davey D A, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988; 158 892-898 16 Davison J M, Homuth V, Jeyabalan A. et al . New aspects in the pathophysiology of preeclampsia. J Am Soc Nephrol. 2004; 15 2440-2448 17 Deutsche Hochdruckliga . Leitlinien für die Prävention, Erkennung, Diagnostik und Therapie der arteriellen Hypertonie - Hochdruck in der Schwangerschaft und Stillperiode. Dtsch Med Wochenschr. 2001; 126 225-229 18 De Swiet M. Blood pressure measurement in pregnancy. Br J Obstet Gynaecol. 1991; 98 239-240 19 De Swiet M, Shennan A. Blood pressure measurement in pregnancy. Br J Obstet Gynaecol. 1996; 103 862-863 20 Easterling T R, Brateng D, Schmucker B, Brown Z, Millard S P. Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Obstet Gynecol. 1999; 93 725-733 21 Friedman E A, Neff R K. Hypertension-hypotension in pregnancy: Correlation with fetal outcome. JAMA. 1978; 239 2249-2251 22 Grunberger W, Leodolter S, Parschalk O. Maternal hypotension: fetal outcome in treated and untreated cases. Gynecologic Obstetric Invest. 1979; 10 32-38 23 Halligan A, O’Brien E, O’Malley K, Mee F, Atkins N, Conroy R. et al . Twenty-four-hour ambulatory blood pressure measurement in a primigravid population. J Hypertens. 1993; 11 869-873 24 Helewa M E, Burrows R F, Smith J, Williams K, Brain P, Rabkin S W. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ. 1997; 157 715-725 25 Johenning A R, Barron W M. Indirect blood pressure measurement in pregnancy: Korotkoff phase 4 versus phase 5. Am J Obstet Gynecol. 1992; 167 577-580 26 Lenfant C. Working group report on high blood pressure in pregnancy. J Clin Hypertens (Greenwich). 2001; 3 75-88 27 Lindheimer M C, Katz A I. Gestation in women with kidney disease: prognosis and management. Clin Obstet Gynaecol. 1987; 1 921-937 28 Magee L A, Ornstein M P, von Dadelszen P. Management of hypertension in pregnancy. BMJ. 1999; 318 1332-1336 29 MacGillivray I, Rose G A, Rowe B. Blood pressure survey in pregnancy. Clin Sci. 1969; 37 395-407 30 Margulies M, Voto L S, Fescina R, Lastra L, Lapidus A M, Schwarcz R. Arterial blood pressure standards during normal pregnancy and their relation with mother-fetus variables. Am J Obstet Gynecol. 1987; 156 1105-1109 31 Middeke M. Arterielle Hypertonie. Georg Thieme Verlag, Stuttgart New York 2005 32 NIH publication No. 00 - 3029, originally printed 1990, revised July 2000. National High Blood Pressure Education Program - Working Group Report on High Blood Pressure in Pregnancy 2000 33 Ng P H, Walters W A. The effects of chronic maternal hypotension during pregnancy. Aust NZ J Obstet Gynaecol. 1992; 32 14-16 34 Owens P E, Lyons S P, O’Brien E T. Arterial hypotension: prevalence of low blood pressure in the general population using ambulatory blood pressure monitoring. J Hum Hypertens. 2000; 14 243-247 35 Page E W, Christianson R. The impact of mean arterial pressure in the middle trimester upon the outcome of pregnancy. Am J Obstet Gynecol. 1976; 125 740-746 36 Perry I J, Wilkinson L S, Shinton R A, Beevers D G. Conflicting views on the measurement of blood pressure in pregnancy. Br J Obstet Gynaecol. 1991; 98 241-243 37 Pryde P G, Sedman A B, Nugent C E. Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol. 1993; 3 1575-1582 38 Qasqas S A, McPherson C, Frishman W H, Elkayam U. Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev. 2004; 12 201-221 39 Rath W. Hypertensive Schwangerschaftserkrankungen. Der Gynäkologe. 1999; 32 432-442 40 Rath W. Das HELLP-Syndrom. Stuttgart, Wiss. Verlagsgesellschaft In: Schwangerschafthochdruck (Heilmann L, Rath W (Hrsgb.) 2002: 236-255 41 Redman C WG, Beilin L J, Bonnar J. Variability in normal and abnormal pregnancy. In: Lindheimer MD, Katz AI, Zuspan FP (eds.): Hypertension in Pregnancy Wiley, New York, 1976: 53 42 Redman C WG, Beilin L J, Bonnar J, Ounsted M K. Fetal outcome in trial of antihypertensive treatment in pregnancy. Lancet. 1976; 2 753-756 43 Redman C WG, Jefferies M. Revised definition of pre-eclampsia. Lancet. 1988; 1 809-812 44 Reiss R E, O’Shaughnessy R W, Quilligan T J, Zuspan F P. Retrospective comparison of blood pressure course during preeclamptic and matched control pregnancies. Am J Obstet Gynecol. 1987; 156 894-898 45 Roberts J M, Cooper D W. Pathogenesis and genetics of pre-eclampsia. Lancet. 2001; 357 53 46 Rosenberg T J, Garbers S, Chavkin W, Chiasson M A. Prepregnancy weight and adverse perinatal outcomes in an ethnically diverse population. Obstet Gynecol. 2003; 102 1022-1027 47 Saji H, Yamamanka M, Hagiwara A, Ijiri R. Losartan and fetal toxic effects. Lancet. 2001; 357 363 48 Sebire N J, Jolly M, Harris J P. et al . Maternal obesity and pregnancy outcome: a study of 287 213 pregnancies in London. Int J Obes Relat Metab Disord. 2001; 25 1175-1182 49 Shennan A, Gupta M, Halligan A, Taylor D J, de Swiet M. Lack of reproducibility in pregnancy of Korotkoff phase IV as measured by mercury sphygmomanometry. Lancet. 1996; 347 139-142 50 Sibai B M, Abdella T N, Anderson G D. Pregnancy outcome in 211 patients with mild chronic hypertension. Obstet Gynecol. 1983; 61 571-576 51 Sibai B M, Dekker G, Kupermin C. Preeclampsia. Lancet. 2005; 365 785-799 52 Steer P J. The definition of pre-eclampsia. Br J Obstet Gynaecol. 1999; 106 753-755 53 Steer P J. et al . Maternal blood pressure in pregnancy, birth weight, and perinatal mortality in first births: prospective study. Br Med J. 2004; 329 1312-1314 54 Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet. 2006; 368 1164-1170 55 Weiss J L, Malone F D, Emig D. et al . Obesity, obstetric complications and cesarean delivery rate - a population-based screening study. Am J Obstet Gynecol. 2004; 190 1091-1097 Prof. Dr. med. Martin Middeke Blutdruckinstitut München Osterwaldstraße 69 80805 München Phone: 0049/89/36103947 Fax: 0049/89/36104026 URL: http://www.blutdruckinstitut.de
